Antibody-Surface Protein Interactions [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Antibody-Surface Protein Interactions [MoA] includes 2 drugs with a combined 10,049 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
10,049
Combined Reports
All Antibody-Surface Protein Interactions [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | Thymoglobulin | 9,286 | 2,371 | 3,004 | 25.5% |
| EQUINE THYMOCYTE IMMUNE GLOBULIN | Lymphocytes 6X | 763 | 155 | 204 | 20.3% |
Common Side Effects in Antibody-Surface Protein Interactions [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Off label use | 1,285 | 381 |
| Pyrexia | 934 | 231 |
| Drug ineffective | 751 | 220 |
| Product use in unapproved indication | 703 | 186 |
| Cytomegalovirus infection | 630 | 173 |
| Transplant rejection | 537 | 42 |
| Cytomegalovirus infection reactivation | 498 | 106 |
| Post transplant lymphoproliferative disorder | 457 | 225 |
| Acute kidney injury | 428 | 151 |
| Pneumonia | 419 | 156 |